
Sign up to save your podcasts
Or


AbbVie buys Allergan for $63 billion in cash and stock. Jason Moser analyzes the pros and cons of the deal. Warren Buffett denies any tension between Berkshire-Hathaway and 3G Capital but, would anyone blame him if there was tension? Plus, Jason shares highlights from his trip to Costa Rica and five stock ideas the trip inspired.
By The Motley Fool4.7
16041,604 ratings
AbbVie buys Allergan for $63 billion in cash and stock. Jason Moser analyzes the pros and cons of the deal. Warren Buffett denies any tension between Berkshire-Hathaway and 3G Capital but, would anyone blame him if there was tension? Plus, Jason shares highlights from his trip to Costa Rica and five stock ideas the trip inspired.

3,237 Listeners

1,497 Listeners

806 Listeners

941 Listeners

533 Listeners

1,182 Listeners

2,186 Listeners

825 Listeners

1,428 Listeners

1,051 Listeners

9,714 Listeners

195 Listeners

829 Listeners

84 Listeners

49 Listeners

1,024 Listeners

50 Listeners